Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Stamos, Daniel Beau ; Barajas-Ochoa, Aldo ; Raybould, Jillian E.
• Description:
  During the SARS-CoV-2 pandemic, few cases of Nocar-dia spp. co-infection have been reported during or after a COVID-19 infection. Nocardia spp. are gram-positive aerobic actinomycetes that stain partially acid-fast, can infect immunocompromised patients, and may cause dis-seminated disease. We report the case of a 52-year-old immunocompromised man who had Nocardia pseudobrasiliensis pneumonia develop after a SARS-CoV-2 in-fection. We also summarize the literature for no-cardiosis and SARS-CoV-2 co-infections. Nocardia spp. infection should remain a part of the differential diagnosis for pneumonia in immunocompromised hosts, regardless of other co-infections. Sulfonamide/carbapenem combina-tions are used as empiric therapy for nocardiosis; species identification and susceptibility testing are required to se-lect the optimal treatment for each patient.
• Subjects:
  • Synopsis
  • Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients
  • nocardiosis
  • co-infection
  • Nocardia pseudobrasiliensis
  • SARS-CoV-2
  • COVID-19
  • opportunistic infections
  • bacteria
  • respiratory infections
  More +
• Source:
  Emerg Infect Dis. 2023; 29(4):696-700
• Pubmed ID:
  36958028
• Pubmed Central ID:
  PMC10045714
• Document Type:
  Journal Article
• Volume:
  29
• Issue:
  4
• Download URL:
  https://stacks.cdc.gov/view/cdc/127671/cdc_127671_DS1.pdf
• File Type:
  [PDF - 1.21 MB]
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:dd12081b5c9060c650cb49c6bf928e4aa9abfdff5b4e770385a7803739501c08